{"id":"https://openalex.org/W4408317147","doi":"https://doi.org/10.3389/fimmu.2025.1542850","title":"Effectiveness and safety of ICIs for the treatment of advanced CC: a systematic review and meta-analysis","display_name":"Effectiveness and safety of ICIs for the treatment of advanced CC: a systematic review and meta-analysis","alternate_titles":[],"publication_year":2025,"publication_date":"2025-03-11","ids":{"openalex":"https://openalex.org/W4408317147","doi":"https://doi.org/10.3389/fimmu.2025.1542850","pmid":"https://pubmed.ncbi.nlm.nih.gov/40134429","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11933070"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2025.1542850","doi":"https://doi.org/10.3389/fimmu.2025.1542850","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2025.1542850","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4408317147"],"child_works_count":1,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fimmu.2025.1542850","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5116583495","display_name":"Nurbia Ibibulla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802734952","display_name":"First Affiliated Hospital of Xinjiang Medical University","ror":"https://ror.org/02qx1ae98","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802734952"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Nurbia Ibibulla","raw_affiliation_strings":["Cancer Center, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China","institution_ids":["https://openalex.org/I2802734952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101835994","display_name":"Pengfei Lu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802734952","display_name":"First Affiliated Hospital of Xinjiang Medical University","ror":"https://ror.org/02qx1ae98","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802734952"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Pengfei Lu","raw_affiliation_strings":["Cancer Center, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China","institution_ids":["https://openalex.org/I2802734952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067325129","display_name":"Yiliyaer Nuerrula","orcid":"https://orcid.org/0000-0002-6037-0172","observed_orcids":["https://orcid.org/0000-0002-6037-0172"]},"institutions":[{"id":"https://openalex.org/I2802734952","display_name":"First Affiliated Hospital of Xinjiang Medical University","ror":"https://ror.org/02qx1ae98","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802734952"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yiliyaer Nuerrula","raw_affiliation_strings":["Cancer Center, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China","institution_ids":["https://openalex.org/I2802734952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120045521","display_name":"Xueqin Hu","orcid":"https://orcid.org/0000-0002-8315-304X","observed_orcids":["https://orcid.org/0000-0002-8315-304X"]},"institutions":[{"id":"https://openalex.org/I2802734952","display_name":"First Affiliated Hospital of Xinjiang Medical University","ror":"https://ror.org/02qx1ae98","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802734952"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xueqin Hu","raw_affiliation_strings":["Cancer Center, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China","institution_ids":["https://openalex.org/I2802734952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116583496","display_name":"Mulati Aihemaiti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802734952","display_name":"First Affiliated Hospital of Xinjiang Medical University","ror":"https://ror.org/02qx1ae98","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802734952"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Mulati Aihemaiti","raw_affiliation_strings":["Cancer Center, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China","institution_ids":["https://openalex.org/I2802734952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125136010","display_name":"Yubo Wang","orcid":"https://orcid.org/0000-0002-2686-8946","observed_orcids":["https://orcid.org/0000-0002-2686-8946"]},"institutions":[{"id":"https://openalex.org/I2802734952","display_name":"First Affiliated Hospital of Xinjiang Medical University","ror":"https://ror.org/02qx1ae98","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802734952"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yubo Wang","raw_affiliation_strings":["Pharmacy Department, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Department, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China","institution_ids":["https://openalex.org/I2802734952"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101305160","display_name":"Hua Zhang","orcid":"https://orcid.org/0000-0002-7098-9294","observed_orcids":["https://orcid.org/0000-0002-7098-9294"]},"institutions":[{"id":"https://openalex.org/I2802734952","display_name":"First Affiliated Hospital of Xinjiang Medical University","ror":"https://ror.org/02qx1ae98","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802734952"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Hua Zhang","raw_affiliation_strings":["Cancer Center, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, China","institution_ids":["https://openalex.org/I2802734952"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101305160","https://openalex.org/A5125136010"],"corresponding_institution_ids":["https://openalex.org/I2802734952"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.3007,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.32470099,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"16","issue":null,"first_page":"1542850","last_page":"1542850"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7714999914169312,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7714999914169312,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.19900000095367432,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.021199999377131462,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/advanced-cervical-cancer","display_name":"advanced cervical cancer","score":0.9229999780654907},{"id":"https://openalex.org/keywords/recurrent-cervical-cancer","display_name":"recurrent cervical cancer","score":0.7070000171661377},{"id":"https://openalex.org/keywords/metastatic-cervical-cancer","display_name":"metastatic cervical cancer","score":0.9139999747276306},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.824999988079071},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9300000071525574},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9549999833106995},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8809999823570251},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.8339999914169312},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.9860000014305115},{"id":"https://openalex.org/keywords/tumor-infiltrating-immune-cells","display_name":"tumor-infiltrating immune cells","score":0.7900000214576721},{"id":"https://openalex.org/keywords/squamous-cell-carcinoma","display_name":"squamous cell carcinoma","score":0.9559999704360962},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.4869999885559082},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.5450000166893005},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.6399999856948853},{"id":"https://openalex.org/keywords/sensitivity-analysis","display_name":"sensitivity analysis","score":0.6859999895095825},{"id":"https://openalex.org/keywords/heterogeneity-assessment","display_name":"heterogeneity assessment","score":0.503000020980835},{"id":"https://openalex.org/keywords/risk-of-bias-assessment","display_name":"risk of bias assessment","score":0.5270000100135803},{"id":"https://openalex.org/keywords/meta-regression","display_name":"meta-regression","score":0.30799999833106995}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8467997908592224},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6768247485160828},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.6765155792236328},{"id":"https://openalex.org/C2778220009","wikidata":"https://www.wikidata.org/wiki/Q160105","display_name":"Cervical cancer","level":3,"score":0.6731212139129639},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5690087676048279},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.56875079870224},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.530725359916687},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43688833713531494},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3522118031978607}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.3389/fimmu.2025.1542850","doi":"https://doi.org/10.3389/fimmu.2025.1542850","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2025.1542850","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11933070","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11933070/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11933070/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:10744840","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11933070","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:40134429","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40134429","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:dfd48ad6b5f54dceb34581c7a4a20f22","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/dfd48ad6b5f54dceb34581c7a4a20f22","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 16 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2025.1542850","doi":"https://doi.org/10.3389/fimmu.2025.1542850","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2025.1542850","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320329258","display_name":"State Key Laboratory of Pathogen and Biosecurity","ror":"https://ror.org/02kdgk225"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4408317147.pdf","grobid_xml":"https://content.openalex.org/works/W4408317147.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W1842042263","https://openalex.org/W2512113963","https://openalex.org/W2531269403","https://openalex.org/W2564174616","https://openalex.org/W2743565010","https://openalex.org/W2766016099","https://openalex.org/W2770798942","https://openalex.org/W2925815206","https://openalex.org/W2955108721","https://openalex.org/W2970684805","https://openalex.org/W3032571309","https://openalex.org/W3083679990","https://openalex.org/W3097683670","https://openalex.org/W3110311626","https://openalex.org/W3118615836","https://openalex.org/W3141004240","https://openalex.org/W3155156689","https://openalex.org/W3200231835","https://openalex.org/W4200215773","https://openalex.org/W4210971182","https://openalex.org/W4213066621","https://openalex.org/W4221059725","https://openalex.org/W4292590106","https://openalex.org/W4295592568","https://openalex.org/W4306164101","https://openalex.org/W4307125413","https://openalex.org/W4309912792","https://openalex.org/W4311471872","https://openalex.org/W4312065982","https://openalex.org/W4313260880","https://openalex.org/W4381988820","https://openalex.org/W4387866410","https://openalex.org/W4387903318","https://openalex.org/W4388124188","https://openalex.org/W4389229205","https://openalex.org/W4389455369","https://openalex.org/W4389728363","https://openalex.org/W4389764706","https://openalex.org/W4390570789","https://openalex.org/W4390955127","https://openalex.org/W4391234157","https://openalex.org/W4392100364","https://openalex.org/W4392509845","https://openalex.org/W4392542858","https://openalex.org/W4393935425","https://openalex.org/W4399054523","https://openalex.org/W4399517501","https://openalex.org/W4400507908","https://openalex.org/W4401117349","https://openalex.org/W4403312202","https://openalex.org/W4403615693","https://openalex.org/W4406079615"],"related_works":["https://openalex.org/W4410290671","https://openalex.org/W7133699118","https://openalex.org/W4405123012","https://openalex.org/W4405075928","https://openalex.org/W4416184697","https://openalex.org/W4311107126","https://openalex.org/W4401644969","https://openalex.org/W7162296473","https://openalex.org/W7161996108","https://openalex.org/W7165121501"],"abstract_inverted_index":{"Background":[0],"The":[1,109,144],"use":[2],"of":[3,29,47,49,137,152,288],"immune":[4,299],"checkpoint":[5,300],"inhibitors":[6,301],"has":[7],"recently":[8],"become":[9],"a":[10,45,184],"promising":[11],"and":[12,26,69,79,100,113,125,135,149,172,186,191,234,260,282,334],"innovative":[13],"therapeutic":[14],"option":[15],"for":[16,51,72,131,316],"patients":[17,248],"suffering":[18],"from":[19],"advanced":[20,52,140,155,308],"recurrent":[21],"or":[22,34],"metastatic":[23],"cervical":[24,141,156,309],"cancer(CC),":[25],"several":[27],"studies":[28,211],"immunotherapy":[30],"have":[31,35],"been":[32],"published":[33],"revealed":[36,242],"stage-by-stage":[37],"results":[38,145,278],"at":[39],"international":[40],"congresses.":[41],"Nevertheless,":[42],"there":[43],"is":[44,329],"lack":[46],"meta-analyses":[48],"ICIs":[50,138,153,160,199,322],"CC":[53],"in":[54,139,154,189,198,232,237,246,263,307,320],"past":[55],"Meta-analysis.":[56],"Method":[57],"This":[58],"meta-analysis":[59,296],"rigorously":[60],"followed":[61],"the":[62,89,96,116,126,133,313],"PRISMA":[63],"guidelines,":[64],"using":[65,95],"Review":[66,338],"Manager":[67],"V.5.4":[68],"R(v4.2.2)":[70],"software":[71],"data":[73],"synthesis.":[74],"Hazard":[75],"ratios,":[76,78],"risk":[77,80],"differences":[81],"were":[82,103,227],"calculated,":[83],"with":[84,183,229],"statistical":[85],"significance":[86],"assessed":[87],"via":[88],"Mantel-Haenszel":[90],"test.":[91],"Heterogeneity":[92],"was":[93,196,290],"evaluated":[94],"Higgins":[97],"I2":[98],"statistic,":[99],"sensitivity":[101],"analyses":[102],"conducted":[104],"if":[105],"heterogeneity":[106,319],"surpassed":[107],"50%.":[108],"efficacy":[110,134,148,262],"outcomes":[111],"examined":[112],"gathered":[114],"included":[115],"overall":[117,123,305],"response":[118],"rate":[119],"(ORR),":[120],"progress-free":[121],"survival,":[122],"survival(OS),":[124],"adverse":[127],"events":[128],"(AEs),":[129],"crucial":[130],"understanding":[132],"safety":[136,151],"cancer.":[142,157],"Result":[143],"demonstrate":[146],"significant":[147,261],"manageable":[150],"In":[158],"RCTs,":[159],"improved":[161],"OS":[162,244,277],"(HR":[163,174,267],"=":[164,175,202,208,217,252,258,268,280],"0.66,":[165],"95%":[166,177,204,219,254],"CI:":[167,178,205,220,255],"0.58-0.75,":[168],"P":[169,180,207,222,257,270],"<":[170,181,223,271],"0.00001)":[171],"PFS":[173],"0.67,":[176,269],"0.59-0.75,":[179],"0.0001),":[182],"34%":[185],"33%":[187],"reduction":[188],"death":[190],"progression":[192],"risks,":[193],"respectively.":[194],"ORR":[195,284],"higher":[197,235],"groups":[200],"(RR":[201],"1.39,":[203],"1.08-1.80,":[206],"0.01).":[209],"Single-arm":[210],"supported":[212],"these":[213],"findings":[214],"(ORR:":[215],"RD":[216],"0.31,":[218],"0.22-0.40,":[221],"0.0001).":[224],"Safety":[225],"profiles":[226],"manageable,":[228],"comparable":[230],"TRAEs":[231],"RCTs":[233],"incidences":[236],"single-arm":[238],"studies.":[239],"Subgroup":[240],"analysis":[241,274],"superior":[243],"benefits":[245],"PD-L1-positive":[247],"(CPS":[249],"\u22651,":[250],"HR":[251],"0.65,":[253],"0.50\u20130.84,":[256],"0.001)":[259],"squamous":[264],"cell":[265],"carcinoma":[266],"0.00001).":[272],"Sensitivity":[273],"confirmed":[275],"robust":[276],"(I\u00b2":[279],"0%)":[281],"stable":[283],"despite":[285],"heterogeneity.":[286],"Risk":[287],"bias":[289],"low":[291],"to":[292,331],"moderate.":[293],"Conclusion":[294],"Our":[295],"reveals":[297],"that":[298],"(ICIs)":[302],"significantly":[303],"prolong":[304],"survival":[306],"cancer":[310],"patients,":[311],"reducing":[312],"hazard":[314],"ratio":[315],"death.":[317],"Despite":[318],"outcomes,":[321],"offer":[323],"substantial":[324],"treatment":[325],"benefits.":[326],"Further":[327],"research":[328],"needed":[330],"optimize":[332],"usage":[333],"monitor":[335],"AEs.":[336],"Systematic":[337],"Registration":[339],"https://www.crd.york.ac.uk/PROSPERO":[340],",":[341],"identifier":[342],"CRD42023387789.":[343]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4408317147","counts_by_year":[{"year":2026,"cited_by_count":3}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2025-03-12T00:00:00"}
